Bruce Dezube
About Bruce Dezube
Bruce Dezube is the Alkermes Fellow and Vice President of Oncology at Alkermes in Waltham, Massachusetts. He has extensive experience in medical leadership, clinical trials, and oncology research, holding multiple scientific patents and authoring over 190 scientific journals.
Company
Bruce Dezube currently works at Alkermes in Waltham, Massachusetts. He holds the title of Alkermes Fellow/Vice President of Oncology, contributing to the company's oncology programs.
Title
Bruce holds the position of Alkermes Fellow/Vice President of Oncology. He has also served as Executive Medical Director at Alkermes from 2019 to 2020.
Previous Positions
Bruce Dezube has an extensive background in the medical field. He was Senior Medical Director at TESARO, Inc. from 2016 to 2019. Prior to that, he was Medical Director at Takeda Oncology and Millennium Pharmaceuticals from 2010 to 2016. He also served as an Attending Physician at Beth Israel Deaconess Medical Center from 1986 to 2010.
Education and Expertise
Bruce earned his Doctor of Medicine (M.D.) from Tufts University School of Medicine. He holds a Master of Arts (M.A.) in Chemistry from Harvard Graduate School of Arts and Sciences. He completed his Bachelor's degree in Chemistry at Rutgers, The State University of New Jersey-New Brunswick. Additionally, he studied at Tel Aviv University for one year.
Scientific Contributions and Certifications
Bruce has authored over 190 scientific journals listed on PubMed and holds scientific patents in oncology. He is Triple Board Certified in Internal Medicine, Hematology, and Oncology.
Clinical and Research Leadership
Bruce has performed due diligence as the clinical lead on multiple biotechnology companies. He has developed clinical trial protocols, created education programs for physicians, and presented extensively at major Academic Medical Centers and international congresses. He has also led the clinical team in developing clinical development plans, protocols, and medical monitoring of multiple clinical trials.
Notable Projects and Initiatives
Bruce has ensured the quality of clinical documents through rigorous timelines, including Clinical Study Reports and Breakthrough Designation Applications. He has fostered relationships with many academic physicians and worked on strategic initiatives.